IBB vs VXUS
iShares Biotechnology ETF vs Vanguard Total International Stock ETF
IBB—
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: —Yield: —
VXUS—
Vanguard Total International Stock ETF
All non-US equities (developed + emerging).
Expense: —Yield: —
Side-by-side metrics
| Metric | IBB | VXUS |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | iShares | Vanguard |
IBB top holdings
Holdings data unavailable for IBB.
VXUS top holdings
Holdings data unavailable for VXUS.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies.
About VXUS
VXUS (Vanguard Total International Stock ETF) is All non-US equities (developed + emerging).